bicalutamide and belinostat

bicalutamide has been researched along with belinostat in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Cesare, E; Festuccia, C; Gravina, GL; Jannini, EA; Lenzi, A; Mancini, A; Marampon, F; Motta, M; Muzi, P; Negri-Cesi, P; Piccolella, M; Tombolini, V1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

2 other study(ies) available for bicalutamide and belinostat

ArticleYear
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer.
    Endocrine-related cancer, 2013, Volume: 20, Issue:3

    Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Castration; Cell Line, Tumor; ErbB Receptors; Exportin 1 Protein; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Histone Deacetylase Inhibitors; Histone Deacetylases; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Karyopherins; Male; Mice; Mice, Nude; Nitriles; Phenotype; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; Sulfonamides; Tosyl Compounds

2013
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013